THE EUROPEAN ATOMIC ENERGY COMMUNITY (EURATOM), REPRESENTED BY THE EUROPEAN COMMISSION;UNIVERSITÄT HEIDELBERG
发明人:
Alfred MORGENSTERN,Frank BRUCHERTSEIFER,Christos APOSTOLIDIS,Uwe HABERKORN,Frederik GIESEL,Clemens KRATOCHWIL
申请号：
US16470104
公开号：
US20200016281A1
申请日:
2016.12.15
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to a method for treating PSMA expressing cancers, wherein the method comprises administering to patient in need thereof an effective amount of one or more Ac-225-radiopharmaceuticals, wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a dosage of from 25 kBq to 400 kBq/kg of body weight of said patient or wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a unitary dosage of from 3 MBq to 30 MBq to said patient.
